Ralph Lauren Corp (NYSE: RL) has reported E.P.S. of $4.76 for its third fiscal quarter (ending December 31) versus $4.25 for the same period a year ago — an increase of 12%. For the latest […]
For its fourth fiscal quarter (ending December 31), Minerals Technologies Inc. (NYSE: MTX) has reported a 39% increase in E.P.S. from $1.22 a year ago to $1.69 in the current quarter. E.P.S. were $5.21 for […]
Lumentum Holdings Inc (NASDAQ: LITE) has reported E.P.S. of $-0.88 for its second fiscal quarter (ending December 31) versus $-1.47 for the same period a year ago — a decline of -40%. E.P.S. were $-7.69 […]
For its first fiscal quarter (ending December 31), Ingles Markets Inc (NASDAQ: IMKTA) has reported a -62% decline in E.P.S. from $2.28 a year ago to $0.87 in the current quarter. For the latest four […]
Fortinet Inc (NASDAQ: FTNT) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.69 versus $0.41 for the same period a year ago — an increase of 68%. For the latest four […]
For its fourth fiscal quarter (ending December 31), Brightsphere Investment Group In (NYSE: BSIG) has reported a 107% increase in E.P.S. from $0.55 a year ago to $1.14 in the current quarter. E.P.S. were $2.25 […]
Boyd Gaming Corp (NYSE: BYD) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.92 versus $0.94 for the same period a year ago — an increase of 104%. For the latest […]
For its first fiscal quarter (ending December 31), Air Products and Chemicals Inc. (NYSE: APD) has reported a 1% increase in E.P.S. from $2.74 a year ago to $2.77 in the current quarter. E.P.S. were […]
Affiliated Managers Group Inc. (NYSE: AMG) has reported E.P.S. of $5.39 for its fourth fiscal quarter (ending December 31) versus $5.83 for the same period a year ago — a decline of -8%. For the […]
For its third fiscal quarter (ending December 31), Advanced Drainage Systems Inc (NYSE: WMS) has reported a -23% decline in E.P.S. from $1.36 a year ago to $1.05 in the current quarter. E.P.S. were $6.03 […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research